|
|
|
Neue Publikationen von Prof. Schönenberger
|
| [meso-1,2-Bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine] dichloroplatinum(II),
a Compound with a Specific Activity on Hormone-Sensitive Breast Cancers
- Evidence for a Diethylstilbestrol-Like Mode of Action Richard Schlemmer,
Thilo Spruß, Günther Bernhardt, Helmut Schönenberger Arch. Pharm.
Pharm. Med. Chem. 1999, 332, 59-69 |
| [meso-1,2-Bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]sulfato-platinum(II)
- Pharmacokinetic Studies Günther Bernhardt, Marion Koch, Thilo
Spruß, Ronald Gust, Rudolf Krauser, Richard Schlemmer, Michael Hollstein,
Franz Lux, Helmut Schönenberger Arch. Pharm. Pharm. Med. Chem. 1999,
332, 195-200 |
| Does [Meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]-dichloroplatinum(II)
Act on the Hormone-Sensitive, Murine Breast Cancer as a Biological
Response Modifier? Part 1: The MXT-M-3.2 Breast Cancer Stimulates
the Growth of an Identical Second Graft; [Meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]dichloroplatinum(II)
Inhibits this Process Richard Schlemmer, Thilo Spruß, Günther Bernhardt,
Helmut Schönenberger Arch. Pharm. Pharm. Med. Chem. 2000, 333, 69-71
|
| Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]-dichloroplatinum
(II) Act on the Hormone-Sensitive, Murine Breast Cancer as a Biological
Response Modifier? Part II. Studies on the Influence of [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]dichloroplatinum(II)
on the Specific Immune Defense in MXT-M-3,2 Breast Cancer Bearing
Mice Richard Schlemmer, Thilo Spruß, Günther Bernhardt, Helmut Schönenberger
Arch. Pharm. Pharm. Med. Chem. 2000, 333, 397-403 |
| Does [meso-1,2-Bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]-dichloro-platinum(II)
Act as an Immune Response Modifier? Part III: Progressively Growing
MXT-M-3,2 Breast Cancer Stimulates the Proliferation of Phagocytes
in B6D2F1 Mice Richard Schlemmer, Thilo Spruß, Günther Bernhardt,
Helmut Schönenberger Arch. Pharm. Pharm. Med. Chem. 2000, 333, 404-414
|
| 1-(2,6-Dichloro-4-hydroxyphenyl)-2-phenylethanes - New Biological
Response Modifiers for the Therapy of Breast Cancer. Synthesis
and Evaluation of Estrogenic/Antiestrogenic Properties Sabine Schertl,
Rolf W. Hartmann, Christine Batzl-Hartmann, Richard Schlemmer, Thilo
Spruß, Günther Bernhardt, Ronald Gust, Helmut Schönenberger Arch.
Pharm. Pharm. Med. Chem. 2001, 334, 125-137 |
| |
| |
|